1567. Perspectives of People with HIV (PWH) 6 Months Following a Switch to Cabotegravir and Rilpivirine Long-acting (CAB+RPV LA) in an Observational Real-world US Study (BEYOND)

BACKGROUND: CAB+RPV LA is the only complete long-acting regimen for treatment of virologically suppressed people with HIV (PWH). Administered monthly or every 2 months by a healthcare provider (HCP), CAB+RPV LA may alleviate challenges associated with daily oral antiretroviral therapy (ART). Perspec...

Descripción completa

Detalles Bibliográficos
Autores principales: Dandachi, Dima, Cunningham, Douglas, Valenti, William M, Phoenix, John, Nguyen, Kaitlin, Teichner, Paula, Jean-Louis, Ashley, Reynolds, Maria, Richardson, David, Garris, Cindy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678594/
http://dx.doi.org/10.1093/ofid/ofad500.1402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678594/
http://dx.doi.org/10.1093/ofid/ofad500.1402

Ejemplares similares